To evaluate the efficacy and safety in patients with Geriatric Depression.
- male or female 65 years of age or older
- experiencing a major depression episode
- failure to respond to an adequate trial of anti-depressant in the current episode.
- Must currently be on an anti-depressant treatment and having an inadequate response